ResMed Inc.
ResMed Inc. (RMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RMD · as of Jun 8, 2026
Key Statistics
Explore ResMed Inc. Data
rmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 35 · Buy rate: 45.7%
The RMD analyst consensus is Buy, based on ratings from 35 Wall Street analysts over the past 3 months. The average 12-month price target is $281.29, representing +43.49% upside from the current price of $196.04.
Competitors & Peers
rmd competitorsRMD
A
ALC
BDX
CAH
GEHCStock Performance
Full HistoryAbout ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respirato…
what is resmed inc. · rmd stock overview · resmed inc. company profile · who is resmed inc. ceo · rmd NYSE · resmed inc. headquarters · resmed inc. business segments
About Stock Overview & Key Data
ResMed Inc. (RMD) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Jun 2, 1995. As of the latest trading session, RMD stock price is $196.04, with a market capitalization of $28.4B. The stock has returned -21.89% over the past 12 months and -18.61% year-to-date.
According to 35 Wall Street analysts, the consensus rating for ResMed Inc. stock is Buy, with an average 12-month price target of $281.29. In fiscal year 2025, ResMed Inc. reported revenue of $5.1B and net income of $1.4B. For detailed data — including ResMed Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ResMed Inc. (RMD) stock price is $196.04. The stock is traded on NYSE under the ticker symbol RMD. The 52-week range is $180.27 – $293.81.